However, despite the initial interest in anti-TNF-α drugs for the treatment of retinal disease [53], in addition to safety concerns, anecdotal case reports provide controversial results on the use of anti-TNF-α drugs in patients with AMD [54,55]. This evidence concerns the gene TNF and age-related macular degeneration.